title: Enhancement of drug efflux activity via MDR1 protein by spheroid culture of human hepatic cancer cells.
abstract: Human hepatic cancer cells, HepG2, formed spheroids on a poly-L-glutamic acid-coated dish. Doxorubicin (DOX) efflux activity of the cells in spheroid culture was higher than that in monolayer culture due to the higher expression of MDR1 protein of the cells in spheroids compared with those in monolayer. The amount of MDR1 per cell in spheroids was similar to that of hepatic tumor tissue in vivo. Consequently, it was suggested that the drug efflux activity of cells in spheroid culture reflected the activity of hepatic cancer cells. Furthermore, the IC(50) of DOX and epirubicin (EPI) in HepG2 cells, both of which are known to be exported by MDR1, were higher in spheroid compared with monolayer cells, while IC(50) of 5-fluorouracil (5-FU), which is not exported by MDR1 protein, was almost the same in both types of culture. The higher IC(50) of DOX and EPI in HepG2 cells in spheroid culture was associated with a higher efflux activity of the drugs in the spheroid-cultured cells, which appeared to reflect the IC(50) of DOX and EPI in cancer cells in vivo. Therefore, a spheroid culture of hepatic cancer cells seems to provide a promising cell-based in vitro assay system for examining the proper IC(50) values of anticancer agents that would reflect the drug resistance of cancer cells in vivo. In addition, the system would be useful in screening for inhibitors of MDR1 activity, which will help to overcome the multidrug resistance of cancer cells.
authors.affiliation: Division of Applied Life Science, Graduate School of Engineering, Sojo University, Ikeda, Kumamoto, Japan.
authors.forename: Ayumi
authors.initials: A
authors.lastname: Oshikata
authors.forename: Taku
authors.initials: T
authors.lastname: Matsushita
authors.forename: Ryuichi
authors.initials: R
authors.lastname: Ueoka
mesh_terms: D018435:ATP Binding Cassette Transporter, Subfamily B; D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1 / Q000378:metabolism*; D018929:Cell Culture Techniques; D004317:Doxorubicin / Q000493:pharmacokinetics*; D018432:Drug Resistance, Multiple / Q000187:drug effects; D019008:Drug Resistance, Neoplasm / Q000187:drug effects; D015251:Epirubicin / Q000493:pharmacokinetics; D005472:Fluorouracil / Q000493:pharmacokinetics; D018698:Glutamic Acid; D056945:Hep G2 Cells; D006801:Humans; D020128:Inhibitory Concentration 50; D018874:Spheroids, Cellular / Q000378:metabolism*
chemical_list: C513055:ABCB1 protein, human; D018435:ATP Binding Cassette Transporter, Subfamily B; D020168:ATP Binding Cassette Transporter, Subfamily B, Member 1; D018698:Glutamic Acid; D015251:Epirubicin; D004317:Doxorubicin; D005472:Fluorouracil